All News
Filter News
Found 2,353 articles
-
Abeona Therapeutics Enrolls First High Dose Subject In Ongoing Phase 1/2 Gene Therapy Clinical Trial In Sanfilippo Syndrome Type A
2/1/2017
-
Agenovir Names Bolyn Hubby, Ph.D., As Chief Scientific Officer
1/31/2017
-
Tony Coles, M.D., Elected To Regeneron Board Of Directors
1/31/2017
-
Cellecta, Inc. Release: Biotech Receives Phase II NIH SBIR Grant To Develop Advanced CRISPR/Cas9 Genome-Wide sgRNA Library Screening Platform
1/26/2017
-
What You Need to Know About Homology Medicines
1/24/2017
-
What You Need to Know About Fulcrum Therapeutics
1/23/2017
-
Abeona Therapeutics Release: Company Receives Orphan Drug Designation In The European Union For ABO-101 Gene Therapy In Sanfilippo Syndrome Type B
1/19/2017
-
Horizon Discovery Ltd. Release: Company Broadens Industry-Leading Gene Editing Capabilities Through Extension Of Key CRISPR License And Grant-Funded Research
1/16/2017
-
JPM17: Vertex Game Plan for Growth in 2017
1/10/2017
-
Emerging Life Science And Biotech Companies Find Critical Success At Mass Innovation Labs
1/9/2017
-
13 Reasons to Watch the J.P. Morgan Healthcare Conference Next Week
1/6/2017
-
Synthego Raises $41 Million In Series B Financing Led By 8VC To Advance CRISPR Genome Engineering
1/5/2017
-
Listen Up Researchers: Versant Ventures to Fund 2 Dozen Biotech Startups With $400 Million
1/4/2017
-
Abeona Therapeutics Receives Orphan Drug Designation In The European Union For ABO-201 Gene Therapy Program In Juvenile Batten Disease
1/3/2017
-
Editas Medicine to Pay Six Academic Centers for Exclusive Rights to a New System That Might Improve CRISPR-Cas9
12/20/2016
-
Cellecta, Inc. Launches A Single-Module 80K Human Genome-Wide CRISPR Knockout Library
12/20/2016
-
Celgene, Evotec AG Ink $295 Million Drug Discovery Pact
12/16/2016
-
BioPharm Executive: So Long 2016 (and Good Riddance?)
12/14/2016
-
Bayer, Versant Ventures Launch BlueRock Therapeutics With $225 Million to Focus on Stem Cell R&D
12/12/2016
-
Meet the 34-Year Old Scientist Who's Transforming CRISPR
12/12/2016